AI cuts lesion measurement time by 34% - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

AI cuts lesion measurement time by 34%

  • By

  • Andrea Surnit

  • September 3, 2026

  • 4 min

Share

Objective:

To evaluate the impact of artificial intelligence (AI) assistance on lesion measurement time and classification agreement in follow-up CT examinations of cancer patients.

Approach:
  • Study Design: A retrospective study involving follow-up chest, abdomen, and pelvis CT examinations from 212 patients with 539 target lesions, evaluated by 15 radiologists and 8 radiology residents under different conditions.
  • Measurement Conditions: Readers assessed lesions under unassisted, AI-assisted, and expert-assisted conditions, remeasuring predefined target lesions according to RECIST 1.1.
  • Outcomes Measured: Primary outcomes included reading time and interobserver measurement variability; secondary outcomes included proposal acceptance, patient-level change in sum of longest diameters (SLD), and RECIST response classification agreement.
Key Findings:
  • AI assistance reduced mean reading time by 34% (from 105 seconds to 71 seconds per patient).
  • Expert-assisted reading was faster at 56 seconds but required an initial unassisted measurement, resulting in a cumulative reading time of 151 seconds.
  • AI assistance increased interreader agreement on RECIST response classification by approximately 8 percentage points compared to unassisted assessment.
  • AI-assisted measurements showed greater deviation from expert-derived reference measurements (mean absolute error of 4.35 mm with AI vs. 3.08 mm without assistance vs. 1.51 mm with expert assistance).
  • Radiologists accepted 61% of AI proposals compared to 77% of expert proposals, with substantial modifications occurring in 23% of AI-assisted measurements.
Interpretation:

AI assistance can accelerate RECIST assessment and improve consistency, but expert assistance yields greater agreement and efficiency.

Limitations:
  • Baseline target lesions were predefined, limiting assessment of interobserver differences in baseline lesion selection.
  • The study did not include new or nontarget lesion assessments, which could affect RECIST outcomes.
  • Measurement variability analysis was biased in favor of expert assistance due to the reference standard used.
  • Different readers evaluated measurements for a given patient across the three conditions, introducing potential confounding.
Conclusion:

AI-assisted RECIST assessment may enhance workflow and consistency in response classification while providing a benchmark for future AI development.

Sources:

Original Source(s)

Related Content